Abbott Laboratories (ABT)
NYSE · Healthcare · Medical Devices
Abbott Laboratories is a Healthcare company with a market capitalization of $163.94B, a trailing P/E ratio of 26.4, and a dividend yield of 2.62%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 16, 2026 | $1.15 | $1.15 | +0.0% |
| Q4 2025 | January 22, 2026 | $1.50 | $1.49 | +0.7% |
| Q3 2025 | October 15, 2025 | $1.30 | $1.30 | +0.0% |
| Q2 2025 | July 17, 2025 | $1.01 | $0.99 | +2.0% |
| Q1 2025 | April 16, 2025 | $0.76 | $0.78 | -2.6% |
| Q4 2024 | January 22, 2025 | $1.34 | $1.34 | +0.0% |
Other Medical Devices Stocks
Frequently Asked Questions
What is Abbott Laboratories's market cap?
As of June 29, 2026, Abbott Laboratories (ABT) has a market capitalization of $163.94B.
What is Abbott Laboratories's P/E ratio?
Abbott Laboratories trades at a trailing price-to-earnings (P/E) ratio of 26.4. Its forward P/E is 17.2.
Does Abbott Laboratories pay a dividend?
Yes — Abbott Laboratories pays a dividend yielding 2.62%, an annual payout of $2.44 per share.
What sector is ABT in?
Abbott Laboratories is in the Healthcare sector, specifically the Medical Devices industry.
What was Abbott Laboratories's revenue?
In its latest reported fiscal year (ending December 31, 2025), Abbott Laboratories reported revenue of $44.33B and net income of $6.52B.
Ask your own questions about ABT
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.